Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by 24minus7on Jun 11, 2022 12:57pm
408 Views
Post# 34749344

@Najajojoe - GO SIRONA GO! - WATCH OUT NEXT WEEK!

@Najajojoe - GO SIRONA GO! - WATCH OUT NEXT WEEK!Well, after more than half a year of nitpicking by BP with well understood a team of 60 professionals provided by BP, you have to admit that Sirona, which manages this work with 3.5 times "full time positions" (!!!), is still standing. As soon as the PoC/PoE/ PoM of the entire Sirona technology is confirmed by the deal with a BP (for emphasis, in this case 56 billion annual turnover), there is no stopping here... ROCKET TIME!

...and to your question, I am convinced that the anti-aging/anti-wrinkle compound is already worth 0.5-1.5 billion at the clinical trial stage. Try to visualise it, market capitalisation compared to CAD 52 million of Sirona. Of course, this only applies if above is confirmed.

See the discrepancy! @navajojoe

And yes, Animal Health... what could this deal look like with 3 cooperating or competing animal health companies? Any idea: everybody? I mean, the company with the blue and white logo from Greenfield was leaked to us involuntarily a while back. All in all, ANIMAL HEALTH - Freaking awesome story!

@Tickel1st: your snarky and damn funny comments, honestly (!!!), are certainly brilliant too when pushing Sirona. Go Linda Go - Howheehole will never get you.

To reiterate, once PoC/PoE/ PoM confirmed by BP, a SP is quite realistic at CAD 1.55 to CAD 2.1 in the next 180 days. Time for a new chapter! Go Team Sirona!
<< Previous
Bullboard Posts
Next >>